<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ometendo</journal-id><journal-title-group><journal-title xml:lang="ru">Ожирение и метаболизм</journal-title><trans-title-group xml:lang="en"><trans-title>Obesity and metabolism</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2071-8713</issn><issn pub-type="epub">2306-5524</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/omet9672</article-id><article-id custom-type="elpub" pub-id-type="custom">ometendo-9672</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Лекция</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Lecture</subject></subj-group></article-categories><title-group><article-title>Гипофосфатемический рахит: патогенез, диагностика и лечение</article-title><trans-title-group xml:lang="en"><trans-title>Hypophosphatemic rickets: pathogenesis, diagnosis and treatment</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0434-9088</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Куликова</surname><given-names>Кристина Сергеевна</given-names></name><name name-style="western" xml:lang="en"><surname>Kulikova</surname><given-names>Kristina S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., научный сотрудник отделения наследственных эндокринопатий ФГБУ НМИЦ эндокринологии</p></bio><bio xml:lang="en"><p>PhD</p></bio><email xlink:type="simple">kristinakulikova87@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8500-4841</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тюльпаков</surname><given-names>Анатолий Николаевич</given-names></name><name name-style="western" xml:lang="en"><surname>Tiulpakov</surname><given-names>Anatoly N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>заведующий отделением наследственных эндокринопатий ФГБУ НМИЦ эндокринологии</p></bio><bio xml:lang="en"><p>ScD</p><p> </p></bio><email xlink:type="simple">ant@endocrincentr.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>&lt;p&gt;ФГБУ Национальный медицинский исследовательский центр эндокринологии Минздрава России&lt;/p&gt;</institution><country>Россия</country></aff><aff xml:lang="en"><institution>&lt;p&gt;Endocrinology Research Centre&lt;/p&gt;</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>28</day><month>07</month><year>2018</year></pub-date><volume>15</volume><issue>2</issue><fpage>46</fpage><lpage>50</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Куликова К.С., Тюльпаков А.Н., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Куликова К.С., Тюльпаков А.Н.</copyright-holder><copyright-holder xml:lang="en">Kulikova K.S., Tiulpakov A.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.omet-endojournals.ru/jour/article/view/9672">https://www.omet-endojournals.ru/jour/article/view/9672</self-uri><abstract><p>Гипофосфатемический рахит (ГФР) – группа заболеваний, характеризующихся развитием рахитических изменений костной ткани вследствие повышенного выведения фосфора из организма. Данная форма рахита является наиболее распространенной среди вариантов генетически детерминированных форм нарушений минерального обмена. ГФР является актуальной медико-социальной проблемой, требующей постоянного обновления знаний как эндокринологов, так и врачей другого профиля. Это обусловлено тем, что клиническая картина ГФР имеет значительную гетерогенность и может проявляться выраженными деформациями скелета, задержкой физического развития, тяжелой мышечной гипотонией, частыми переломами, абсцессами зубов, что в ряде случаев приводит к инвалидизации пациента и, соответственно, снижает качество жизни. Своевременная диагностика и адекватная терапия ГФР имеет крайне важное значение для предотвращения развития тяжелых осложнений.</p><p>В настоящее время известны более 10 генов-кандидатов, дефекты в которых приводят к развитию врожденных форм ГФР. Генетическая диагностика ГФР имеет большое значение для определения формы ГФР, а также для проведения генетического консультирования семей при планировании беременности.</p></abstract><trans-abstract xml:lang="en"><p>Hypophosphatemic rickets (HR) - a group of diseases characterized by the development of ricketic changes in bone tissue due to increased excretion of phosphorus from the body. This form of rickets is the most common among variants of genetically determined forms of disturbances in mineral metabolism. HR is an actual medical and social problem, requiring constant updating of knowledge of both endocrinologists and doctors of other profile. This is due to the fact that the clinical picture of HR has a significant heterogeneity and can manifest as severe deformations of the skeleton, delay in physical development, severe muscle hypotension, frequent fractures, tooth abscesses, which in some cases leads to disability of the patient and, accordingly, reduces the quality of life. Timely diagnosis and adequate therapy of HR is extremely important for preventing the development of severe complications. Currently, more than 10 candidate genes are known, the defects in which lead to the development of congenital forms of GFR. Genetic diagnostics of the HR is of great importance for determining the form of the HR, and for carrying out genetic counseling of families when planning pregnancy.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>uипофосфатемический рахит</kwd><kwd>деформации ног</kwd><kwd>мышечная слабость</kwd><kwd>абсцессы зубов</kwd><kwd>фактор роста фибробластов 23</kwd><kwd>PHEX</kwd><kwd>гипофосфатемия</kwd><kwd>гиперфосфатурия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hypophosphatemic rickets</kwd><kwd>leg deformities</kwd><kwd>muscle weakness</kwd><kwd>abscesses of the teeth</kwd><kwd>fibroblast growth factor 23</kwd><kwd>PHEX</kwd><kwd>hypophosphatemia</kwd><kwd>hyperphosphaturia</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Amatschek S, Haller M, Oberbauer R. Renal phosphate handling in human - what can we learn from hereditary hypophosphataemias? Eur. J. Clin. Invest. 2010;40(6):552-560. doi: 10.1111/j.1365-2362.2010.02286.x.</mixed-citation><mixed-citation xml:lang="en">Amatschek S, Haller M, Oberbauer R. Renal phosphate handling in human - what can we learn from hereditary hypophosphataemias? Eur. J. Clin. Invest. 2010;40(6):552-560. doi: 10.1111/j.1365-2362.2010.02286.x.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Carpenter TO. The expanding family of hypophosphatemic syndromes. J. Bone Miner. Metab.2011;30(1):1-9. doi: 10.1007/s00774-011-0340-2.</mixed-citation><mixed-citation xml:lang="en">Carpenter TO. The expanding family of hypophosphatemic syndromes. J. Bone Miner. Metab.2011;30(1):1-9. doi: 10.1007/s00774-011-0340-2.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Carpenter TO, Imel EA, Holm IA, et al. A clinician's guide to X-linked hypophosphatemia. J. Bone Miner. Res. 2011;26(7):1381-1388. doi: 10.1002/jbmr.340.</mixed-citation><mixed-citation xml:lang="en">Carpenter TO, Imel EA, Holm IA, et al. A clinician's guide to X-linked hypophosphatemia. J. Bone Miner. Res. 2011;26(7):1381-1388. doi: 10.1002/jbmr.340.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Raeder H, Rafaelsen S, Bjerknes R. Monogenic phosphate balance disorders. Contemporary Aspects of Endocrinology: InTech; 2011.</mixed-citation><mixed-citation xml:lang="en">Raeder H, Rafaelsen S, Bjerknes R. Monogenic phosphate balance disorders. Contemporary Aspects of Endocrinology: InTech; 2011.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Francis F, Hennig S, Korn B, et al. A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets. Nat. Genet. 1995;11(2):130-136. doi: 10.1038/ng1095-130.</mixed-citation><mixed-citation xml:lang="en">Francis F, Hennig S, Korn B, et al. A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets. Nat. Genet. 1995;11(2):130-136. doi: 10.1038/ng1095-130.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tenenhouse H. Molecular basis of renal disease. X-linked hypophosphataemia: a homologous disorder in humans and mice. Nephrology Dialysis Transplantation. 1999;14(2):333-341. doi: 10.1093/ndt/14.</mixed-citation><mixed-citation xml:lang="en">Tenenhouse H. Molecular basis of renal disease. X-linked hypophosphataemia: a homologous disorder in humans and mice. Nephrology Dialysis Transplantation. 1999;14(2):333-341. doi: 10.1093/ndt/14.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mansour-Hendili L, Blanchard A, Le Pottier N, et al. Mutation Update of theCLCN5Gene Responsible for Dent Disease 1. Hum. Mutat. 2015;36(8):743-752. doi: 10.1002/humu.22804.</mixed-citation><mixed-citation xml:lang="en">Mansour-Hendili L, Blanchard A, Le Pottier N, et al. Mutation Update of theCLCN5Gene Responsible for Dent Disease 1. Hum. Mutat. 2015;36(8):743-752. doi: 10.1002/humu.22804.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bianchine JW, Stambler AA, Harrison HE. Familial hypophosphatemic rickets showing autosomal dominant inheritance. Birth Defects Orig. Artic. Ser. 1971;7(6):287-295.</mixed-citation><mixed-citation xml:lang="en">Bianchine JW, Stambler AA, Harrison HE. Familial hypophosphatemic rickets showing autosomal dominant inheritance. Birth Defects Orig. Artic. Ser. 1971;7(6):287-295.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">White KE, Evans WE, O'Riordan JLH, et al. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 2000;26(3):345-348. doi: 10.1038/81664.</mixed-citation><mixed-citation xml:lang="en">White KE, Evans WE, O'Riordan JLH, et al. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat. Genet. 2000;26(3):345-348. doi: 10.1038/81664.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Jonsson KB, Zahradnik R, Larsson T, et al. Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia. N. Engl. J. Med. 2003;348(17):1656-1663. doi: 10.1056/NEJMoa020881.</mixed-citation><mixed-citation xml:lang="en">Jonsson KB, Zahradnik R, Larsson T, et al. Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia. N. Engl. J. Med. 2003;348(17):1656-1663. doi: 10.1056/NEJMoa020881.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Avitan-Hersh E, Tatur S, Indelman M, et al. Postzygotic HRAS Mutation Causing Both Keratinocytic Epidermal Nevus and Thymoma and Associated With Bone Dysplasia and Hypophosphatemia Due to Elevated FGF23. J. Clin. Endocr. Metab. 2014;99(1):E132-E136. doi: 10.1210/jc.2013-2813.</mixed-citation><mixed-citation xml:lang="en">Avitan-Hersh E, Tatur S, Indelman M, et al. Postzygotic HRAS Mutation Causing Both Keratinocytic Epidermal Nevus and Thymoma and Associated With Bone Dysplasia and Hypophosphatemia Due to Elevated FGF23. J. Clin. Endocr. Metab. 2014;99(1):E132-E136. doi: 10.1210/jc.2013-2813.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lorenz-Depiereux B, Benet-Pages A, Eckstein G, et al. Hereditary Hypophosphatemic Rickets with Hypercalciuria Is Caused by Mutations in the Sodium-Phosphate Cotransporter Gene SLC34A3. The American Journal of Human Genetics. 2006;78(2):193-201. doi: 10.1086/499410.</mixed-citation><mixed-citation xml:lang="en">Lorenz-Depiereux B, Benet-Pages A, Eckstein G, et al. Hereditary Hypophosphatemic Rickets with Hypercalciuria Is Caused by Mutations in the Sodium-Phosphate Cotransporter Gene SLC34A3. The American Journal of Human Genetics. 2006;78(2):193-201. doi: 10.1086/499410.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Carpenter TO, Imel EA, Ruppe MD, et al. Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia. J. Clin. Invest. 2014;124(4):1587-1597. doi: 10.1172/jci72829.</mixed-citation><mixed-citation xml:lang="en">Carpenter TO, Imel EA, Ruppe MD, et al. Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia. J. Clin. Invest. 2014;124(4):1587-1597. doi: 10.1172/jci72829.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mielke CH, Stevens PM. Hemiepiphyseal stapling for knee deformities in children younger than 10 years: a preliminary report. J. Pediatr. Orthop. 1996;16(4):423-429.</mixed-citation><mixed-citation xml:lang="en">Mielke CH, Stevens PM. Hemiepiphyseal stapling for knee deformities in children younger than 10 years: a preliminary report. J. Pediatr. Orthop. 1996;16(4):423-429.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Novais E, Stevens PM. Hypophosphatemic Rickets. Journal of Pediatric Orthopaedics. 2006;26(2):238-244. doi: 10.1097/01.bpo.0000218531.66856.b7.</mixed-citation><mixed-citation xml:lang="en">Novais E, Stevens PM. Hypophosphatemic Rickets. Journal of Pediatric Orthopaedics. 2006;26(2):238-244. doi: 10.1097/01.bpo.0000218531.66856.b7.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
